GSE186460 baricitinib 0 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE186460_baricitinib_0_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE186460_baricitinib_0_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE186460_baricitinib_0_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE186460_baricitinib_0_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

Pvt1 oncogene

Gene

long intergenic non-protein coding RNA 205

Gene

activator of HSP90 ATPase homolog 2, pseudogene

Gene

HLA complex group 11

Gene

NF-kappaB interacting lncRNA

Gene

TGF-beta induced TARBP2 interacting lncRNA

Gene

long intergenic non-protein coding RNA 942

Gene

HMGA2 antisense RNA 1

Gene

prostate cancer associated transcript 1

Gene

VIM antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 205


  • Gene

    activator of HSP90 ATPase homolog 2, pseudogene


  • Gene

    HLA complex group 11


  • Gene

    NF-kappaB interacting lncRNA


  • Gene

    TGF-beta induced TARBP2 interacting lncRNA


  • Gene

    long intergenic non-protein coding RNA 942


  • Gene

    HMGA2 antisense RNA 1


  • Gene

    prostate cancer associated transcript 1


  • Gene

    VIM antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.